AYP Healthcare Ltd 09701711 false 2024-08-01 2025-07-31 2025-07-31 The principal activity of the company is supplier of pharmaceutical products. Digita Accounts Production Advanced 6.30.9574.0 true 09701711 2024-08-01 2025-07-31 09701711 2025-07-31 09701711 bus:Director1 1 2025-07-31 09701711 bus:OrdinaryShareClass1 2025-07-31 09701711 core:CurrentFinancialInstruments 2025-07-31 09701711 core:CurrentFinancialInstruments core:WithinOneYear 2025-07-31 09701711 core:Non-currentFinancialInstruments 2025-07-31 09701711 core:Non-currentFinancialInstruments core:AfterOneYear 2025-07-31 09701711 core:Goodwill 2025-07-31 09701711 core:FurnitureFittingsToolsEquipment 2025-07-31 09701711 core:LandBuildings 2025-07-31 09701711 core:MotorVehicles 2025-07-31 09701711 bus:SmallEntities 2024-08-01 2025-07-31 09701711 bus:AuditExemptWithAccountantsReport 2024-08-01 2025-07-31 09701711 bus:FilletedAccounts 2024-08-01 2025-07-31 09701711 bus:SmallCompaniesRegimeForAccounts 2024-08-01 2025-07-31 09701711 bus:RegisteredOffice 2024-08-01 2025-07-31 09701711 bus:Director1 2024-08-01 2025-07-31 09701711 bus:Director1 1 2024-08-01 2025-07-31 09701711 bus:Director2 2024-08-01 2025-07-31 09701711 bus:OrdinaryShareClass1 2024-08-01 2025-07-31 09701711 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 09701711 bus:Agent1 2024-08-01 2025-07-31 09701711 core:Goodwill 2024-08-01 2025-07-31 09701711 core:PatentsTrademarksLicencesConcessionsSimilar 2024-08-01 2025-07-31 09701711 core:FurnitureFittingsToolsEquipment 2024-08-01 2025-07-31 09701711 core:LandBuildings 2024-08-01 2025-07-31 09701711 core:MotorVehicles 2024-08-01 2025-07-31 09701711 core:PlantMachinery 2024-08-01 2025-07-31 09701711 countries:EnglandWales 2024-08-01 2025-07-31 09701711 2024-07-31 09701711 bus:Director1 1 2024-07-31 09701711 core:Goodwill 2024-07-31 09701711 core:FurnitureFittingsToolsEquipment 2024-07-31 09701711 core:LandBuildings 2024-07-31 09701711 core:MotorVehicles 2024-07-31 09701711 2023-08-01 2024-07-31 09701711 2024-07-31 09701711 bus:Director1 1 2024-07-31 09701711 bus:OrdinaryShareClass1 2024-07-31 09701711 core:CurrentFinancialInstruments 2024-07-31 09701711 core:CurrentFinancialInstruments core:WithinOneYear 2024-07-31 09701711 core:Non-currentFinancialInstruments 2024-07-31 09701711 core:Non-currentFinancialInstruments core:AfterOneYear 2024-07-31 09701711 core:Goodwill 2024-07-31 09701711 core:FurnitureFittingsToolsEquipment 2024-07-31 09701711 core:LandBuildings 2024-07-31 09701711 core:MotorVehicles 2024-07-31 09701711 bus:Director1 1 2023-08-01 2024-07-31 09701711 bus:Director1 1 2023-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09701711

AYP Healthcare Ltd
Unaudited Filleted Financial Statements
for the Year Ended 31 July 2025

AYP Healthcare Ltd

Contents

Company Information | 1
Statement of Financial Position | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 12

AYP Healthcare Ltd

Company Information

Directors | Mr Zaakir Badat Mr Haroon Badat

Registered office | 160-164 Lancaster Road North Preston PR1 2PZ

Accountants | AIMS Accountants For Business Chartered Certified AccountantsHarewood House 2-6 Rochdale Road Middleton Manchester M24 6DP

AYP Healthcare Ltd

(Registration number: 09701711)
Statement of Financial Position as at 31 July 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 4 | 132,000 | 148,500
Tangible assets | 5 | 680,365 | 572,100
|  | 812,365 | 720,600
Current assets |  |  |
Stocks | 6 | 911,762 | 822,382
Debtors | 7 | 940,825 | 1,091,317
Investments | 8 | 62,851 | 112,851
Cash at bank and in hand |  | 82,163 | 44
|  | 1,997,601 | 2,026,594
Creditors: Amounts falling due within one year | 9 | (1,845,689) | (1,766,794)
Net current assets |  | 151,912 | 259,800
Total assets less current liabilities |  | 964,277 | 980,400
Creditors: Amounts falling due after more than one year | 9 | (305,362) | (392,589)
Net assets |  | 658,915 | 587,811
Capital and reserves |  |  |
Called up share capital | 10 | 100 | 100
Retained earnings |  | 658,815 | 587,711
Shareholders' funds |  | 658,915 | 587,811

AYP Healthcare Ltd

(Registration number: 09701711)
Statement of Financial Position as at 31 July 2025

For the financial year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 4 June 2026 and signed on its behalf by:

......................................... Mr Zaakir Badat Director

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
160-164 Lancaster Road North
Preston
PR1 2PZ

These financial statements were authorised for issue by the Board on 4 June 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Motor vehicles | Reducing Balance 18%
Plant & Machinery and Equipment | Reducing Balance 18%

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Licenses | Tested annually for impairment
Goodwill | Straight Line 10%

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.
Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.
Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.
Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the income statement over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 12 (2024 - 28).

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

4 | Intangible assets

| Goodwill £ | Total £
Cost or valuation
At 1 August 2024 | 165,000 | 165,000
At 31 July 2025 | 165,000 | 165,000
Amortisation
At 1 August 2024 | 16,500 | 16,500
Amortisation charge | 16,500 | 16,500
At 31 July 2025 | 33,000 | 33,000
Carrying amount
At 31 July 2025 | 132,000 | 132,000
At 31 July 2024 | 148,500 | 148,500

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

5 | Tangible assets

| Land and buildings £ | P & M, Furniture, fittings and equipment £ | Motor vehicles £ | Total £
Cost or valuation
At 1 August 2024 | 210,000 | 485,003 | 94,153 | 789,156
Additions | - | 136,598 | 78,746 | 215,344
Disposals | - | - | (9,306) | (9,306)
At 31 July 2025 | 210,000 | 621,601 | 163,593 | 995,194
Depreciation
At 1 August 2024 | - | 171,275 | 45,781 | 217,056
Charge for the year | - | 81,058 | 22,192 | 103,250
Eliminated on disposal | - | - | (5,477) | (5,477)
At 31 July 2025 | - | 252,333 | 62,496 | 314,829
Carrying amount
At 31 July 2025 | 210,000 | 369,268 | 101,097 | 680,365
At 31 July 2024 | 210,000 | 313,728 | 48,372 | 572,100

Included within the net book value of land and buildings above is £210,000 (2024 - £210,000) in respect of freehold land and buildings.

6 | Stocks

| 2025 £ | 2024 £
Other inventories | 911,762 | 822,382

7 | Debtors

| 2025 £ | 2024 £
Trade debtors | 769,844 | 1,008,426
Other debtors | 170,981 | 82,891
| 940,825 | 1,091,317

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

8 | Current asset investments

| 2025 £ | 2024 £
Other investments | 62,851 | 112,851

9 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 11 | 277,846 | 518,805
Trade creditors |  | 1,170,229 | 1,085,459
Taxation and social security |  | 66,211 | 50,463
Other creditors |  | 331,403 | 112,067
|  | 1,845,689 | 1,766,794

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 11 | 305,362 | 392,589

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

10 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary Shares of £1 each | 100 | 100 | 100 | 100

11 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 221,213 | 298,483
Other borrowings | 84,149 | 94,106
| 305,362 | 392,589

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 232,310 | 453,405
Bank overdrafts | 23,618 | 54,134
Other borrowings | 21,918 | 11,266
| 277,846 | 518,805

AYP Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 July 2025

12 | Dividends

|  | 2025 |  | 2024
|  | £ |  | £
Interim dividend of £5.00 (2024 - £10.00) per ordinary share |  | 500 |  | 1,000

13 | Related party transactions

Transactions with directors

2025 | At 1 August 2024 £ | Repayments by director £ | At 31 July 2025 £
Mr Zaakir Badat
Directors current account | (91,914) | (221,096) | (313,010)

2024 | At 1 August 2023 £ | Repayments by director £ | At 31 July 2024 £
Mr Zaakir Badat
Directors current account | (53,205) | (38,709) | (91,914)

Directors' remuneration

The directors' remuneration for the year was as follows:

| 2025 £ | 2024 £
Remuneration | 16,167 | 15,000